Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) has been a common nosocomial pathogen since 1961 1 ; this class of MRSA is now called hospital-acquired MRSA (HA-MRSA). HA-MRSA generally possesses staphylococcal cassette chromosome mec (SCCmec) type I, II, or III and is multidrugresistant. 1, 2 The traditional healthcare-associated risk for acquisition of MRSA includes surgery, residence in a longterm care facility, dialysis, indwelling percutaneous medical devices and catheters, and age (50e60 years and older). 3e6 Previous studies 7e12 and our unpublished data (in 2006e2011) suggested that multilocus sequence type (ST) 5/SCCmecII MRSA (the epidemic New York/Japan clone) is currently the predominant clone in hospitals in Japan; this clone in Japan is also characterized by the carriage of SaPIm1/n1 (with the tst, sec, and sel genes) and enterotoxin gene cluster (egc; with the seg, sei, sem, sen, and seo genes) and multiple-drug resistance (including levofloxacin or fosfomycin resistance). The New York/Japan clone (Japanese type with SaPIm1/n1) has also been isolated from Taiwan. 13 Another class of MRSA, designated community-acquired MRSA (CA-MRSA), emerged in the community from 1997 to 1999. 1, 5, 14 CA-MRSA generally carries SCCmec type IV or V, is resistant to b-lactam agents only or to some agents belonging to limited classes, and often produces PantoneValentine leukocidin (PVL), 1, 5, 14 which causes apoptosis and necrosis in human polymorphonuclear cells or monocytes. 15 CA-MRSA infections are associated mainly with skin and soft tissue infections (SSTIs), but occasionally with invasive infections such as bacteremia (and sepsis) and necrotizing pneumonia in healthy individuals, especially children and adolescents (such as athletes) or even the elderly 1,3e5,14 ; median ages of CA-MRSA and HA-MRSA patients are 23 and 68 years, respectively. 3 ST8/SCCmecIVa MRSA USA300, the most common CA-MRSA clone in the United States, is one of the most wellcharacterized CA-MRSA 2, 16 ; USA300 is positive for PVL and the arginine catabolic mobile element (ACME), and produced a greater amount of cytolytic peptide [phenolsoluble modulins (PSMs) or d-hemolysin (Hld)] than HA-MRSA. 16 In Japan, the New York/Japan clone (HA-MRSA) has also been spreading in the community, among healthy children and pediatric outpatients, 17 and even on public transport 18 ; however, the association of this New York/Japan clone (nasal or public transport MRSA) with diseases in the community has not been reported. In this report, we describe the first necrotizing pneumonia case caused by the New York/Japan MRSA clone in the community in Japan. In this study, CA-MRSA and HA-MRSA were classified according to a previous definition 4 ; CA-MRSA is defined as MRSA isolated from outpatients with no history of hospitalization within at least the past year and who presented with no other established risk factors for HA-MRSA infections (except age). Figure 1 . (A) Chest X-ray on days 6e13 and the (B) transaxial and coronal sections of chest CT on day 10 of a patient with community-acquired necrotizing pneumonia. In (A), arrows indicate pulmonary infiltrates with multiple cavity lesions in the right middle lung field; they showed fast radiological progression (days 6e13). Bilateral pulmonary infiltrates in the lungs are also seen. In (B), multiple cavity lesions within the consolidation are seen in the right upper and middle lobes.
An 89-year-old man was admitted to a hospital on March 14, 2007 (day 1), because of progressive dyspnea. White blood cell count and C-reactive protein were 9300/mL and 11.5 mg/dL, respectively. Chest computed tomography revealed centrilobular nodules mainly in the right lung, with a small volume of right pleural effusion. He had hemoptysis on day 4 and disseminated intravascular coagulation on day 6. On the same day, chest radiography revealed multiple cavities in the right lung (Fig. 1A) . Since MRSA was detected upon sputum culture (including day 1), necrotizing pneumonia by MRSA was suspected (blood culture examination was negative for MRSA). Although he was treated with teicoplanin (800 or 400 mg/day), clindamycin (1.2 g/day), and pazufloxacin (1 g/day), increased multiple cavities and bilateral pleural effusion were observed on day 10 ( Fig. 1B) , and multiple organ failure developed. He died on day 15. He had had no risk factors for HA-MRSA in the past year and no previous MRSA infections. His MRSA, epidemiologically classified as CA-MRSA, was named NPk1.
Next, we investigated the molecular characteristics of MRSA strain NPk1. Molecular typing and virulence gene analysis were performed as described previously. 13, 19 Susceptibility testing of MRSA was carried out using the agar dilution method according to previous procedures described by the Clinical and Laboratory Standards Institute. 20 Breakpoints for drug resistance were those described by the Clinical and Laboratory Standards Institute. 20 MRSA strain NPk1 shared the same genotype (ST5/ spa2[t002]/agr2/SCCmecII.1.1.1[II]/CoaII) and the same virulence genes (including SaPIm1/n1 and egc) as the epidemic New York/Japan clone of HA-MRSA (reference strains Mu50 and N315), as shown in Table 1 . Strain NPk1 was multidrug-resistant, but to fewer classes of agents than the reference strains (e.g., strain NPk1 was susceptible to fosfomycin).
Since staphylococcal superantigens, such as toxic shock syndrome toxin-1 (TSST-1) and staphylococcal enterotoxin B, are associated with pulmonary disease in an animal model 21 and ST8 CA-MRSA/J (a major CA-MRSA in Japan, which was associated with invasive infections including necrotizing pneumonia) produced TSST-1 at a high level, 19 TSST-1 production levels (the amount of TSST-1 in the supernatant of bacterial cultures at 2.0 Â l0 9 cfu/ml) were examined using a TST-RPLA kit (Denka Seiken, Tokyo, Japan). The TSST-1 production level of strain NPk1 was 200 mg/ml, and was relatively similar to those of the New York/Japan clone, including reference strains [Mu50 (800 mg/ml) and N315 (50 mg/ml)] and clinical isolates from TSS patients [I6 (200 mg/ml) and I8 (200 mg/ml)], although the TSST-1 production level of strain NPk1 was lower than that of ST8 CA-MRSA/J (6400 mg/ml). 19 Finally, the mRNA expression levels of the cytolytic peptide genes [psma (encoding PSMa) and hld (encoding Hld)], hla (encoding a-hemolysin, Hla; alternatively named a-toxin), and 16S rRNA genes were examined by reverse transcription-polymerase chain reaction (RT-PCR) assay, as described previously. 19 Briefly, total RNA was extracted and purified from the bacterial cells, cultured at 37 C for 8 h, using the RNAprotect Bacteria Reagent and RNeasy Mini Kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. RT of the RNA sample was achieved using the SuperScript First-Strand Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. The cDNA products of the psma, hld, hla, and 16S rRNA genes were amplified by PCR using the reported PCR primers. 13, 22, 23 PCR products were electrophoresed on 2% agarose gel and then stained with ethidium bromide. After visualization of PCR products by ultraviolet illumination, band intensity was determined using image processing and analyzing software (NIH Image; NIH, Bethesda, MD, USA), and psma, hld, or hla expression was normalized by 16S rRNA expression. For statistical analysis, data were evaluated by Student's t-test. The level of significance was defined as p < 0.05. As shown in Fig. 2 , for either the psma or hld gene, mRNA expression levels of community isolates of the New York/Japan clone (including strain NPk1) were similar to those of ST8 CA-MRSA USA300, but significantly higher than those of inpatient isolates of the New York/Japan clone (p < 0.05). In contrast, the mRNA expression levels of the hla gene were similar among the three groups (community and inpatient isolates of the New York/Japan clone and USA300) (Fig. 2) .
Discussion
This study represents the first case of fatal communityacquired pneumonia (CAP), with rapid progression and cavity formation (with pleural effusion), caused by the New York/Japan clone (strain NPk1). Although pleural infiltrates with multiple nodular and cavity lesions have been noted especially for necrotizing pneumonia caused by PVLpositive CA-MRSA, 24 this study was a PVL-negative case. Moreover, cavity formation may be observed in some cases of CAP from methicillin-susceptible S. aureus and Klebsiella pneumoniae and in septic pulmonary embolism, but it is not usually observed in HA-MRSA infections in Japan; therefore, this case indicates the involvement of a strong virulence factor(s) (other than PVL) in the pathogenesis of fatal necrotizing pneumonia.
In the case of USA300, remarkable virulence markers involve PVL (possibly related to pneumonia, albeit with controversial data in animal models), 15 ACME (possibly related to colonization), 16 Hla (possibly related to necrotizing pneumonia), 16 and enhanced production levels of cytolytic peptides PSMs and Hld (possibly related to invasive infections) 16 ; the hla, psm, and hld genes are generally present in all S. aureus strains. PSMa (20e22 amino acids) and Hld (26 amino acids) cause cell lysis of human polymorphonuclear neutrophils and are also a potent inducer of chemotaxis and interleukin-8 production of polymorphonuclear neutrophils. 25 Strain NPk1 was negative for the PVL gene and ACME; however, it expressed the cytolytic peptide (PSMa and Hld) genes at higher levels than HA-MRSA (New York/Japan clone); the expression levels were similar to USA300 and a successful CA-MRSA clone (ST8 CA-MRSA/J) in Japan, which we recently characterized as a cause of CAP, 19 indicating that strain NPk1 is a variant of the New York/Japan clone with an important feature of CA-MRSA.
Strain NPk1 also produced Hla and TSST-1; the expression levels of the hla gene were similar among HA-and CA-MRSA strains examined, and the TSST-1 production level of strain NPk1 was similar to those of HA-MRSA inpatient strains. We speculate that the combination (in synergy) of a high amount of cytolytic peptides (PSMa and Hld), Hla, superantigens (such as TSST-1), and others contributed to the pathogenesis of severe MRSA CAP in Japan (although the patient was elderly in this case).
In Japan, the New York/Japan clone has mainly been isolated in hospitals, but it has also been isolated from children (mainly 5-to 9-year-old) in the community (albeit at low frequencies: 0.4% [1/274] ); no nasal MRSA has been isolated from university students (<0.2%; 0/526). 17 Children are frequently treated as outpatients at hospitals near their homes, so it is conceivable that some children carry the New York/Japan clone from hospitals, and transmission of such MRSA occurs among their family members, because Figure 2 . The levels of mRNA expression for cytolytic peptide genes (psma and hld ) and hla of MRSA strain NPk1, compared to those of the New York/Japan clone (Japanese type) and USA300. Community isolates of the New York/Japan clone included strain NPk1 (Table 1) and two isolates from a child and public transport. Inpatient isolates of the New York/Japan clone (n Z 8) included reference strains Mu50 and N315 (Table 1) , two MRSA isolates from patients with toxic shock syndrome, and four isolates from sputum and blood, which were randomly selected. USA300 included USA300-0114, a type strain of USA300 (it was kindly provided by L.K. McDougal and L.L. McDonald), and three clinical isolates in Japan. psma, hld, or hla expression was normalized by 16S rRNA expression. Data (mean AE SD) were obtained from three experiments.
MRSA colonizing the nares could also be detected on their hands. 2, 23 This may be the case even for elderly people. Most probably reflecting these situations, the New York/ Japan clone is also detected from the straps and handrails of trains (public transport) in Japan 18 ; of 15 MRSA isolates, two were the New York/Japan clone (13.3%).
These community isolates of the New York/Japan clone expressed the cytolytic peptide (PSMa and Hld) genes at high levels (similar to NPk1), in contrast to inpatient isolates of the New York/Japan clone. There is a possibility that the New York/Japan clone with enhanced expression of the cytolytic peptide genes has been selected in the community and caused fatal CAP in an elderly individual. This case may pose a threat, since the elderly population has been increasing. Further detailed analysis with more strains is needed.
